| Accession |
PRJCA020319 |
| Title |
FZPL-III-302 Fluzoparib or fluzoparib plus apatinib mesylate versus placebo in a phase III clinical study of advanced ovarian cancer |
| Relevance |
Medical |
| Data types |
Involves nucleic acid biomarker data
|
| Organisms |
Homo sapiens
|
| Description |
Involves nucleic acid biomarker data |
| Sample scope |
Multiisolate |
| Release date |
2023-10-07 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
jiao
liu (jiao.liu.jl119@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co., Ltd |
| Submission date |
2023-10-07 |
